SOD1 and age-related macular degeneration: To examine whether the treatment of MED can protect against the reduction in antioxidative capacity in AMD, we measured the alterations in the SOD activity and expression, and the Nrf2 expression in MED + A2E + BL treated ARPE19 cells.